Ocular Therapeutix (OCUL)
NASDAQ:OCUL
Holding OCUL?
Track your performance easily

Ocular Therapeutix (OCUL) Financial Statements

1,377 Followers

Ocular Therapeutix Financial Overview

Ocular Therapeutix's market cap is currently ―. The company's EPS TTM is $-1.354; its P/E ratio is -6.47; Ocular Therapeutix is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 16.44M$ 14.77M$ 14.80M$ 15.08M$ 15.19M
Gross Profit$ 14.93M$ 13.45M$ 13.41M$ 13.70M$ 13.88M
EBIT$ -43.78M$ -55.65M$ -25.07M$ 2.91M$ -18.69M
EBITDA$ -42.25M$ -52.76M$ -24.11M-$ -16.79M
Net Income Common Stockholders$ -43.78M$ -64.85M$ -29.22M$ -516.00K$ -20.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 459.69M$ 482.89M$ 195.81M$ 110.55M$ 66.61M
Total Assets$ 517.09M$ 538.95M$ 252.06M$ 162.38M$ 122.56M
Total Debt$ 74.89M$ 74.41M$ 83.39M$ 83.02M$ 64.77M
Net Debt$ -384.80M$ -408.48M$ -112.42M$ -27.53M$ -1.84M
Total Liabilities$ 139.40M$ 130.96M$ 160.93M$ 154.53M$ 119.47M
Stockholders Equity$ 377.69M$ 407.98M$ 91.13M$ 7.85M$ 3.09M
Cash Flow-
Free Cash Flow$ -25.54M$ -34.14M$ -22.91M-$ -22.07M
Operating Cash Flow$ -24.80M$ -33.89M$ -22.45M$ -7.73M$ -20.07M
Investing Cash Flow$ -742.00K$ -255.00K$ -459.00K$ -259.00K$ -1.99M
Financing Cash Flow$ 2.20M$ 321.22M$ 108.17M$ 51.94M$ 9.64M
Currency in USD

Ocular Therapeutix Earnings and Revenue History

Ocular Therapeutix Debt to Assets

Ocular Therapeutix Cash Flow

Ocular Therapeutix Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis